Trius Therapeutics Inc's ability to collect accounts receivable sequentially worsen to 3.84, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Trius Therapeutics Inc's Accounts Receivable average collection period in the Jun 30 2013 quarter, has increased to 95 days, from 92 days, in the Mar 31 2013 quarter.

If we take a look into Healthcare sector 290 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2013 from 2957 to 3078.

What is Receivable Turnover Ratio?
What is Trius Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TSRX Receivables Turnover Ratio	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter
Y / Y Receivable Change	-70.13 %	-57.69 %	33.38 %	1.36 %	201.22 %
Y / Y Revenue Change	-79.26 %	-82.43 %	3.1 %	-80.38 %	117.7 %
Receivable Turnover Ratio (TTM)	3.84	3.97	4.85	5.15	9.84
TSRX's Total Ranking	# 3078	# 2957	# 2714	#	#
Accounts Receivable average collection period days	95	92	75	71	37
Seq. Receivable Change	-17.93 %	-58.99 %	19.08 %	-25.49 %	16.26 %
Seq. Revenue Change	-25.25 %	-66.51 %	-13.68 %	-4.03 %	-36.7 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 33
Healthcare Sector	# 291
Overall Market	# 3078

Receivable Turnover Ratio Statistics
High	Average	Low
4.85	4.22	3.84
(Dec 31 2012)		(Jun 30 2013)

TSRX Company Profile • Back to TSRX Efficiency Comparisons • Compare TSRX Receivables Turnover Ratio to its Competitors

Financial Statements
Trius Therapeutics Inc's Accounts Receivable	$ 2 Millions	Visit TSRX's Balance sheet
Trius Therapeutics Inc's Sales TTM	$ 14 Millions	Visit TSRX's Income Statement
Sources of TSRX's Revenues		Visit TSRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TSRX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TSRX's Growth Rates	TSRX's Roa	TSRX's Inventory Turnover Ratio	TSRX's Dividend Comparisons
TSRX's Profitability Ratios	TSRX's Roi	TSRX's Asset Turnover Ratio	TSRX's Dividend Growth
TSRX's Valuation Ratios	TSRX's Roe	TSRX's Financial Strength Ratios	TSRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2013, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2013	Receivable at quarter ending Jun 30 2013
Sunlink Health Systems Inc	19.97	$ 108.308 Millions	$ 5.423 Millions
Guided Therapeutics Inc	19.94	$ 2.094 Millions	$ 0.105 Millions
Nektar Therapeutics	19.88	$ 96.424 Millions	$ 4.851 Millions
Alaunos Therapeutics Inc	18.39	$ 0.800 Millions	$ 0.044 Millions
Adma Biologics Inc	18.15	$ 3.015 Millions	$ 0.166 Millions
Cyteir Therapeutics Inc	17.77	$ 1,917.300 Millions	$ 107.875 Millions
Achari Ventures Holdings Corp I	17.07	$ 116.486 Millions	$ 6.824 Millions
Lftd Partners Inc	17.02	$ 3.163 Millions	$ 0.186 Millions
Oragenics Inc	16.81	$ 1.039 Millions	$ 0.062 Millions
Chemed Corporation	14.54	$ 1,446.769 Millions	$ 99.515 Millions
Aspira Women s Health inc	13.96	$ 2.112 Millions	$ 0.151 Millions
Ligand Pharmaceuticals Incorporated	13.67	$ 41.241 Millions	$ 3.017 Millions
International Stem Cell Corporation	13.60	$ 5.176 Millions	$ 0.381 Millions
Musclepharm Corporation	13.51	$ 83.106 Millions	$ 6.151 Millions
Dyne Therapeutics Inc	13.35	$ 1,408.000 Millions	$ 105.500 Millions
Soligenix inc	13.13	$ 4.677 Millions	$ 0.356 Millions
Wearable Health Solutions, Inc.	12.82	$ 0.573 Millions	$ 0.045 Millions
Acorda Therapeutics Inc	12.73	$ 317.828 Millions	$ 24.974 Millions
Vivosim Labs Inc	12.71	$ 1.139 Millions	$ 0.090 Millions
Exelixis Inc	12.61	$ 42.652 Millions	$ 3.383 Millions
China Biologic Products Holdings Inc	12.60	$ 194.732 Millions	$ 15.457 Millions
Stablecoin Development Corporation	12.48	$ 6.544 Millions	$ 0.524 Millions
Statera Biopharma Inc fka Cytocom Inc	12.09	$ 5.362 Millions	$ 0.443 Millions
Agenus Inc	12.04	$ 3.875 Millions	$ 0.322 Millions
American Caresource Holdings, Inc.	11.97	$ 31.334 Millions	$ 2.618 Millions
Immucell Corporation	11.82	$ 9.037 Millions	$ 0.765 Millions
Rockwell Medical inc	11.47	$ 51.010 Millions	$ 4.447 Millions
Interpace Biosciences Inc	11.32	$ 147.581 Millions	$ 13.041 Millions
Curis Inc	11.08	$ 8.540 Millions	$ 0.771 Millions
Adynxx, Inc.	11.03	$ 1.665 Millions	$ 0.151 Millions

Date modified: 2026-06-22T14:31:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.